DNM1 Gene Early Infantile Epileptic Encephalopathy Type 31 Genetic Test
At DNA Labs UAE, we offer the DNM1 Gene Early Infantile Epileptic Encephalopathy Type 31 Genetic Test for the diagnosis of a rare genetic disorder characterized by seizures that begin in the first few months of life. This test is designed to identify any mutations in the DNM1 gene, which is associated with early infantile epileptic encephalopathy type 31 (EIEE31).
Test Details
The DNM1 gene provides instructions for making a protein involved in the process of endocytosis, which is the uptake of materials into cells. Mutations in this gene can cause EIEE31. Our NGS genetic testing method involves sequencing the DNM1 gene to identify any mutations that may be causing the condition.
Test Components and Price
The DNM1 Gene Early Infantile Epileptic Encephalopathy Type 31 Genetic Test is priced at 4400.0 AED. The test requires a blood sample or extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Test Type
After the sample is collected, the report will be delivered within 3 to 4 weeks. This test falls under the category of neurological disorders and is conducted by our specialized Genetics department.
Doctor and Pre Test Information
This test is recommended for patients with a clinical history of early infantile epileptic encephalopathy type 31. We advise patients to consult with a neurologist and undergo a genetic counseling session to draw a pedigree chart of family members affected by the condition.
Treatment and Supportive Care
If diagnosed with EIEE31, the typical treatment involves the use of antiepileptic medications and supportive care. Our test can not only aid in the diagnosis of the disorder but also provide information about the risk of passing it on to future children.
| Test Name | DNM1 Gene Early infantile epileptic encephalopathy type 31 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for DNM1 Gene Early infantile epileptic encephalopathy type 31 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DNM1 Gene Early infantile epileptic encephalopathy type 31 |
| Test Details |
The DNM1 gene is associated with early infantile epileptic encephalopathy type 31 (EIEE31), a rare genetic disorder characterized by seizures that begin in the first few months of life. The condition is caused by mutations in the DNM1 gene, which provides instructions for making a protein involved in the process of endocytosis, the uptake of materials into cells. NGS genetic testing for EIEE31 involves sequencing the DNM1 gene to identify any mutations that may be causing the condition. This test can be helpful in diagnosing the disorder, as well as providing information about the risk of passing the condition on to future children. Treatment for EIEE31 typically involves antiepileptic medications and supportive care. |
